Unnecessary Screening | CAR T-Cell Therapy | Videos for Parents, Cancer Information Highlights, September 9, 2020

Unnecessary Screening | CAR T-Cell Therapy | Videos for Parents, Cancer Information Highlights, September 9, 2020

Cancer Information Highlights

From the National Cancer Institute

Updating you about cancer causes, prevention, screening, treatment, coping, and more

New from NCI Many Older Adults Receive Unnecessary Screening for Common Cancers   Many older adults are being screened for cancer when they no longer need to be. Based on a nationwide survey, a study found that at least half of older US adults had received at least one unnecessary cancer screening test in the last few years. CAR T-Cell Therapy for Mantle Cell Lymphoma   The Food and Drug Administration (FDA) has approved a new CAR T-cell therapy for mantle cell lymphoma. Learn more about this latest CAR T-cell therapy approval. Support for Families When a Child Has Cancer Videos for parents of children with cancer have been added to this page. Learn tips for talking with your child and their siblings about cancer. Get answers from other parents and children to commonly asked questions. Aspirin and Cancer in Older People   In healthy people aged 70 or older, taking a daily low-dose aspirin may increase their risk of being diagnosed with advanced cancer and dying from cancer. Learn more about the results from a large clinical trial. Heart Attack May Make Breast Cancer Grow Faster Studies in mice have shown that a heart attack speeds breast tumor growth. And human studies have linked heart events with breast cancer coming back after treatment. Read how a heart attack may lead to changes in the immune system that affect cancer growth. FDA Approvals Azacitidine for Acute Myeloid Leukemia We’ve updated our drug summary for azacitidine (Onureg). FDA recently approved it to treat certain adults who had a complete remission after intensive induction therapy and are not able to complete intensive curative therapy. New Treatment for Multiple Myeloma We’ve updated our drug summaries for carfilzomib (Kyprolis) and daratumumab (Darzalex). FDA recently approved this drug combo for the treatment of relapsed or refractory multiple myeloma in people who have received one to three other types of therapy.

Also of Interest Heart Problems: Studying the Cardiac Side Effects of Cancer Treatments Certain cancer treatments can damage the heart and the cardiovascular system. This NCI Cancer Currents blog post from 2018 covers what is known about these problems and discusses future research directions. Contact Us for Help Information specialists at NCI’s Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email.